ACR
Acrosin
Also known as: ACRO_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P10323
- Gene
- ACR
- Ensembl
- ENSG00000100312
- Chromosome
- 22
- Canonical length
- 421 aa
- Protein class
- Enzymes, Predicted secreted proteins
- Secretome location
- Secreted in male reproductive system
OverviewNCBI Gene
Acrosin is the major proteinase present in the acrosome of mature spermatozoa. It is a typical serine proteinase with trypsin-like specificity. It is stored in the acrosome in its precursor form, proacrosin. The active enzyme functions in the lysis of the zona pellucida, thus facilitating penetration of the sperm through the innermost glycoprotein layers of the ovum. The mRNA for proacrosin is synthesized only in the postmeiotic stages of spermatogenesis. In humans proacrosin first appears in the haploid spermatids. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
421 residues, UniProt reviewed canonical sequence.
>P10323|ACR
1 MVEMLPTAIL LVLAVSVVAK DNATCDGPCG LRFRQNPQGG VRIVGGKAAQ HGAWPWMVSL
61 QIFTYNSHRY HTCGGSLLNS RWVLTAAHCF VGKNNVHDWR LVFGAKEITY GNNKPVKAPL
121 QERYVEKIII HEKYNSATEG NDIALVEITP PISCGRFIGP GCLPHFKAGL PRGSQSCWVA
181 GWGYIEEKAP RPSSILMEAR VDLIDLDLCN STQWYNGRVQ PTNVCAGYPV GKIDTCQGDS
241 GGPLMCKDSK ESAYVVVGIT SWGVGCARAK RPGIYTATWP YLNWIASKIG SNALRMIQSA
301 TPPPPTTRPP PIRPPFSHPI SAHLPWYFQP PPRPLPPRPP AAQPRPPPSP PPPPPPPASP
361 LPPPPPPPPP TPSSTTKLPQ GLSFAKRLQQ LIEVLKGKTY SDGKNHYDME TTELPELTST
421 SLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 81 nTPM
Expression across tissuesHPA
Tissue
- testis: 81 nTPM
- spleen: 2.8 nTPM
- adipose tissue: 2.4 nTPM
- breast: 1.9 nTPM
- lung: 1.9 nTPM
- endometrium: 1 nTPM
Single-cell type
- late spermatids: 71 nCPM
- early spermatids: 37 nCPM
- late primary spermatocytes: 22 nCPM
- sertoli cells: 1.4 nCPM
- proximal tubule cells: 0.8 nCPM
- podocytes: 0.5 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 5 nTPM
- basal ganglia: 0.7 nTPM
- pons: 0.7 nTPM
- cerebral cortex: 0.6 nTPM
- cerebellum: 0.5 nTPM
- spinal cord: 0.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ACR.
Disease | AllUniProt
Conditions ACR is implicated in, by any mechanism.
- Spermatogenic failure 87 (SPGF87) MIM:620500
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 84 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Spermatogenic failure 87
ReferencesPubMed · IEDB
Publications for ACR from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
4 publications
- Antisperm antibody binding to human acrosin: a study of patients with unexplained infertility.
1991 · Fertil Steril · RCR 0.8 · 16 citations - Acrosin antibodies and infertility. I. Detection of antibodies towards proacrosin/acrosin in women consulting for infertility and evaluation of their effects upon the sperm protease activities.
2009 · Fertil Steril · RCR 0.5 · 12 citations - Antiacrosin antibodies and infertility. II. Gene immunization with human proacrosin to assess the effect of immunity toward proacrosin/acrosin upon protein activities and animal fertility.
2009 · Fertil Steril · RCR 0.3 · 8 citations - Guinea pig testicular proacrosin-acrosin system: preliminary immunological characterization.
1989 · J Reprod Immunol · RCR 0 · 1 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.88
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.45
- DepMap mean gene effect
- -0.16
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- acrosome reaction
- activation of adenylate cyclase activity
- binding of sperm to zona pellucida
- penetration of zona pellucida
- response to steroid hormone
- single fertilization
- acrosome matrix dispersal
Molecular functions
- amidase activity
- copper ion binding
- D-mannose binding
- DNA binding
- fucose binding
- protease binding
- serine-type endopeptidase activity
- serine-type peptidase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACR as an antibody target. Whether an autoantibody or antibody against ACR could matter depends on whether native ACR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACR is annotated as secreted, so native ACR circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label ACR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...